Φορτώνει......
Circulating levels of anti-angiogenic VEGF-A isoform (VEGF-A(xxx)b) in colorectal cancer patients predicts tumour VEGF-A ratios
Purpose: Bevacizumab as an adjunct to chemotherapy improves survival for some patients with metastatic colorectal cancer. Immunohistochemical staining of samples from the registration ECOG E3200 trial of bevacizumab with FOLFOX demonstrated that only patients with carcinomas expressing low levels of...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Am J Cancer Res |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
e-Century Publishing Corporation
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4529627/ https://ncbi.nlm.nih.gov/pubmed/26269767 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|